Impact of IGF-1R/EGFR cross-talks on hepatoma cell sensitivity to gefitinib-Reference-Cited by-同舟云学术

Impact of IGF-1R/EGFR cross-talks on hepatoma cell sensitivity to gefitinib

Published:2006 Issue:11 Volume:119 Page:2557-2566
ISSN:0020-7136
Container-title:International Journal of Cancer
language:en
Short-container-title:Int. J. Cancer

Author:

Desbois-Mouthon Christèle,Cacheux Wulfran,Blivet-Van Eggelpoël Marie-José,Barbu Véronique,Fartoux Laetitia,Poupon Raoul,Housset Chantal,Rosmorduc Olivier

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference54 articles.

1. Gefitinib — a novel targeted approach to treating cancer

2. ERBB receptors and cancer: the complexity of targeted inhibitors

3. Expression and clinical significance of erb-B receptor family in hepatocellular carcinoma

4. Transforming growth factor alpha (TGFα) in hepatocellular carcinomas and adjacent hepatic parenchyma

Cited by 102 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. TAPI-1 Exhibits Anti-tumor Efficacy in Human Esophageal Squamous Cell Carcinoma Cells via Suppression of NF-κB Signaling Pathway;Digestive Diseases and Sciences;2023-11-26

2. The Role of IGF/IGF-1R Signaling in Hepatocellular Carcinomas: Stemness-Related Properties and Drug Resistance;International Journal of Molecular Sciences;2021-02-16

3. S6K1 blockade overcomes acquired resistance to EGFR-TKIs in non-small cell lung cancer;Oncogene;2020-10-09

4. TNF-α Induces URG-4/URGCP Gene Expression in Hepatoma Cells through Starvation Dependent Manner;Biochemical Genetics;2020-10-09

5. Multiple Growth Factor Targeting by Engineered Insulin-like Growth Factor Binding Protein-3 Augments EGF Receptor Tyrosine Kinase Inhibitor Efficacy;Scientific Reports;2020-02-17